ALX Oncology Holdings (ALXO) Earnings Call Presentation

ALX2004 Potential First- and Best-In-Class EGFR-targeted ADC May 2025 NASDAQ GS ALXO © ALX Oncology Inc. All rights reserved. Forward-Looking Statements Certain information set forth in this presentation contains "forward-looking information", under applicable laws collectively referred to herein as forward-looking statements. Except for statements of historical fact, information contained herein constitutes forward-looking statements and includes, but is not limited to the (i) results and cost and timing o ...